Acculi Labs, a deep-tech life growth solution provider, has successfully raised $1.5 million in a new funding round led by Sabi Holding India Ltd, reaching a valuation of $25 million. This marks a significant milestone for the Bengaluru-based startup, which had previously secured Rs 5 crore in seed funding from PirE Ventures in 2020.
The fresh capital infusion will be directed towards accelerating the development of Acculi Labs’ conscious AI insights systems, enhancing manpower, improving operational efficiency, and expanding infrastructure. These initiatives aim to bolster the company’s mission of making home-based care readily accessible to patients.
Founded in May 2017 by Rupam Das and Hari Prasath M, Acculi Labs has made notable strides in the healthcare sector with its flagship product, Lyfas. This innovative platform facilitates easy and regular early diagnostics and monitoring for early-stage asymptomatic patients, enabling them to consult their doctors at the earliest stages of potential health issues.
Lyfas, which initially focused on cardiac health assessment, has evolved into a comprehensive suite of health solutions. The mobile application is capable of non-invasively capturing psychophysiological biomarkers and delivering a detailed health report within three minutes, making it a powerful tool for early diagnostics.
In addition to Lyfas, Acculi Labs has developed Lyra, a state-of-the-art conscious AI that bridges the gap between carbon and silicon life forms. This AI-driven approach enhances the accuracy and efficiency of health assessments, providing users with actionable insights for better health management.
Furthermore, Acculi Labs has launched the Lyfas Udyam initiative, aimed at creating a micro-entrepreneurial circular economy. This initiative empowers small entrepreneurs to start and run their businesses by leveraging the ecosystem, processes, and financial support provided by Acculi Labs.
With the new funding and its innovative healthcare solutions, Acculi Labs is poised to make significant advancements in AI-driven healthcare, contributing to better health outcomes and improved quality of life for patients.
